Cancer Drug Resistance
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.6 | Q1 | 85.3% | 1.775 | Q1 | 94.1% |
| 2024 | 5.2 | Q1 | 80.7% | 1.495 | Q1 | 92.2% |
| 2023 | 4.6 | Q1 | 73.8% | 1.035 | Q1 | 86.4% |
| 2022 | 3.7 | 56.1% | 0.815 | Q2 | 81.0% | |
| 2021 | — | — | 0.611 | Q2 | 73.4% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2578-532X
country
UScoverage
2018-2025